George Washington University Hematology and Medical Oncology Best Practices On Demand 2026

George Washington University Hematology and Medical Oncology Best Practices On Demand 2026

GW Hematology & Oncology Best Practices 2026 | ABIM Board Review, Benign Hematology, Leukemia, Lymphoma, Multiple Myeloma, Bone Marrow Transplantation, Immunotherapy, Solid Tumors & Precision Oncology

The George Washington University Hematology and Medical Oncology Best Practices On Demand 2026 is a comprehensive, high-yield educational program designed for physicians preparing for Hematology and Medical Oncology board certification and for clinicians seeking a detailed review of current standards of cancer and blood disease management.

Developed by The George Washington University School of Medicine and Health Sciences, the program brings together leading national faculty to present evidence-based clinical updates, emerging scientific findings, diagnostic principles, contemporary treatment recommendations, and board-focused educational content.

Directed by Robert S. Siegel, MD, the course provides extensive coverage of benign hematology, transfusion medicine, malignant hematology, bone marrow transplantation, pharmacology of antineoplastic agents, cellular therapies, precision oncology, and major solid tumors.

The original 2026 conference took place August 7–13, 2026, in Arlington, Virginia, and the official on-demand program allows eligible registered learners to review recorded scientific presentations and educational materials.

The 2026 Hematology and Oncology Best Practices curriculum follows an examination-oriented structure informed by the American Board of Internal Medicine (ABIM) Hematology and Medical Oncology certification blueprints.

The educational content combines didactic lectures, cellular morphology review, clinical scenarios, and board-style questions to support preparation across major hematology and oncology topics.

Course Details

• Course: George Washington University Hematology and Medical Oncology Best Practices On Demand 2026
• Official Program: 2026 Hematology and Oncology Best Practices
• Provider: George Washington University School of Medicine and Health Sciences
• Course Director: Robert S. Siegel, MD
• Edition: 2026
• Original Conference Dates: August 7–13, 2026
• Original Conference Location: Arlington, Virginia, USA
• Original Venue: The Ritz-Carlton, Pentagon City
• Format: On-Demand Professional Education
• Primary Specialty: Hematology / Oncology
• Additional Focus: Benign Hematology, Hematopathology, Transfusion Medicine, Hematologic Malignancies, Medical Oncology and Cellular Therapy
• Language: English
• Original Full-Program Accreditation: Up to 61 AMA PRA Category 1 Credits™
• Original Full-Program MOC: Up to 61 ABIM MOC Points
• Original Official Platform Access: Through December 31, 2027
• Educational Approach: Expert Lectures, Board Review Sessions, Case-Based Questions and Clinical Updates

The CME and access details refer to the official university program and are not included automatically with independently distributed educational materials.

Program Structure

The 2026 course is organized into major sections addressing:

1. Foundational and Benign Hematology
2. Hematologic Malignancies
3. Medical Oncology
4. Home-Study Educational Materials
5. Interactive Board Review and Case-Based Learning

The original university program includes recorded educational sessions, an electronic syllabus, and slide handouts for eligible registered participants.

The exact number of digital files included with a separate MedicalAmboss product has not been independently confirmed.

Target Audience

The course is designed for physicians preparing for Hematology and Medical Oncology examinations and healthcare professionals seeking a comprehensive specialty update.

The target audience includes:

• Hematologists
• Medical Oncologists
• Hematologist-Oncologists
• Hematopathologists
• Transfusion Medicine Specialists
• Neuro-Oncologists
• Gynecologic Oncologists
• Urologic Oncologists
• Gastrointestinal Oncologists
• Thoracic Oncologists
• Breast Oncologists
• Dermatologists
• Endocrinologists
• Palliative Care Specialists
• Medical Geneticists
• Oncology Pharmacists
• Clinical Pharmacists
• Hematology Fellows
• Oncology Fellows
• Internal Medicine Residents
• Nurse Practitioners
• Physician Assistants
• Oncology Nurses
• Advanced Practice Providers
• Other Healthcare Professionals Involved in Cancer and Blood Disorder Care

Program Overview

Hematology and medical oncology require broad clinical knowledge spanning normal hematopoiesis, blood cell abnormalities, coagulation, immunohematology, malignant hematology, cancer pharmacology, molecular diagnosis, and treatment of solid tumors.

The GW Hematology and Oncology Best Practices 2026 program provides an integrated educational review of these disciplines.

Major topics include:

• Hematopoiesis
• Red Blood Cell Disorders
• Anemia
• Iron Deficiency
• Hemolysis
• Hemoglobinopathies
• Sickle Cell Disease
• White Blood Cell Disorders
• Platelet Disorders
• Coagulation
• Thrombosis
• Transfusion Medicine
• Bone Marrow Failure
• Hematopathology
• Cellular Morphology
• Hematopoietic Stem Cell Transplantation
• Acute Leukemia
• Chronic Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Plasma Cell Disorders
• Antineoplastic Pharmacology
• Cellular Immunotherapy
• Melanoma
• Breast Cancer
• Lung Cancer
• Gastrointestinal Malignancies
• Genitourinary Cancers
• Gynecologic Cancers
• Neuro-Oncology
• Endocrine Malignancies
• Sarcomas
• Precision Oncology
• Supportive and Palliative Care

Learning Objectives

Hematology

Upon completion of the original educational program, learners should be better able to:

1. Understand established concepts and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors.
2. Review developments in coagulopathies, anticoagulant treatment, and thrombolytic therapies.
3. Interpret blood and bone marrow morphology in the context of hematopathology.
4. Recognize and evaluate red blood cell disorders.

Hematologic Malignancies

5. Understand recent developments in the pharmacology and toxicology of antineoplastic medications.
6. Evaluate and manage major hematologic malignancies according to contemporary evidence.
7. Apply effective strategies when preparing for Hematology and Medical Oncology board examinations.

Medical Oncology

8. Understand the epidemiology of malignant diseases and approaches to managing cancer-related medical complications.
9. Review management principles for gynecologic and genitourinary malignancies.
10. Recognize advances in the diagnosis and treatment of lung, breast, and gastrointestinal cancers.
11. Understand emerging biologic and immune-based cancer therapies.
12. Review clinical challenges involving HIV-associated malignancies.

Complete Official 2026 Curriculum by Session

The following is based on the published 2026 university course structure. Each section summarizes the verified subject groups without inventing individual lecture titles or faculty assignments.

Home Study / Enduring Sessions

Anemias

Covers the classification, diagnostic evaluation, and management considerations of common and complex anemias.

Important topics include:

• Microcytic Anemia
• Macrocytic Anemia
• Normocytic Anemia
• Iron Deficiency
• Vitamin B12 Deficiency
• Folate Deficiency
• Hemolytic Anemia
• Diagnostic Laboratory Testing
• Peripheral Blood Smear Interpretation

Porphyrias and Red Cell Enzyme Disorders

Reviews inherited and acquired disorders involving heme metabolism and red cell enzymatic pathways.

Important areas include:

• Porphyrias
• Red Cell Enzymopathies
• Hemolysis
• Enzyme Deficiencies
• Diagnostic Evaluation
• Genetic Considerations

Clotting and Hemostasis

Reviews physiological mechanisms of coagulation and common disorders affecting hemostasis.

Cellular Morphology

Provides review of peripheral blood and bone marrow morphology relevant to clinical hematology and hematopathology.

Liquid Biopsies

Examines emerging applications of circulating tumor DNA and other minimally invasive molecular approaches in oncology.

Mesothelioma

Reviews the diagnosis, classification, and contemporary management considerations of malignant mesothelioma.

Live Session 1 – Benign Hematology and Transfusion Medicine

Immune Thrombocytopenia

Relevant topics include:

• Immune Thrombocytopenia
• Platelet Counts
• Bleeding Risk
• Diagnostic Evaluation
• Treatment Selection
• Long-Term Management

Drug-Induced Thrombocytopenia

Examines medication-associated reductions in platelet counts and appropriate diagnostic considerations.

Consumptive Thrombohemorrhagic Disorders

Reviews complex hematological syndromes involving thrombosis, platelet consumption, and bleeding.

Hemolytic Anemia

Important considerations include:

• Hemolysis
• Red Cell Destruction
• Hemolytic Laboratory Markers
• Immune Hemolysis
• Differential Diagnosis
• Treatment Planning

Hemophilias

Reviews inherited coagulation factor deficiencies, bleeding manifestations, and treatment principles.

Transfusion Medicine

Relevant topics include:

• Blood Component Therapy
• Transfusion Indications
• Compatibility
• Transfusion Reactions
• Patient Safety
• Blood Bank Practices

Hematologic Complications of Pregnancy

Reviews clinically important hematologic conditions affecting pregnancy.

Platelet Alloimmunization

Examines immune responses to platelet antigens and implications for transfusion management.

Live Session 2 – Benign Hematology, Thrombosis and Transplantation

Sickle Cell Disease and Hemoglobinopathies

Relevant areas include:

• Sickle Cell Disease
• Hemoglobin Variants
• Clinical Complications
• Disease-Modifying Treatment
• Transfusion Considerations

Iron Deficiency

Reviews diagnostic laboratory assessment and contemporary treatment approaches.

Bone Marrow Failure and White Blood Cell Disorders

Important topics include:

• Aplastic Anemia
• Marrow Failure Syndromes
• Leukopenia
• Neutropenia
• White Cell Abnormalities
• Bone Marrow Evaluation

Disseminated Intravascular Coagulation

Examines systemic activation of coagulation and related complications.

Heparin-Induced Thrombocytopenia

Reviews the diagnosis and management of HIT.

Vaccine-Induced Immune Thrombotic Thrombocytopenia

Examines recognition and management principles involving VITT.

Ischemic Limb Gangrene and ABO Incompatibility

Reviews selected hematologic, vascular, and transfusion-related complications.

Hematopoietic Transplantation

Introduces clinical principles involving hematopoietic cell transplantation and related patient care.

Live Session 3 – Hematologic Malignancies

Lymphomas

Reviews major lymphoma categories, diagnostic assessment, staging, and treatment developments.

Multiple Myeloma and Plasma Cell Disorders

Important topics include:

• Multiple Myeloma
• MGUS
• Plasma Cell Dyscrasias
• Diagnostic Criteria
• Risk Assessment
• Treatment Selection
• Monitoring

Acute Lymphoblastic Leukemia

Reviews diagnosis and treatment approaches in ALL.

Chronic Myeloid Leukemia

Examines CML biology, molecular testing, and targeted treatment.

Myelodysplastic Syndromes

Reviews MDS classification, risk stratification, and treatment considerations.

Waldenström Macroglobulinemia

Examines this lymphoplasmacytic disorder and its clinical management.

Palliative Care

Reviews symptom relief, supportive care, and patient-centered decision-making in hematologic malignancy management.

Live Session 4 – Advanced Malignant Hematology and Cellular Therapy

Acute Myeloid Leukemia

Important subjects include:

• AML Classification
• Molecular Risk Stratification
• Induction and Consolidation Therapy
• Targeted Treatments
• Treatment Toxicities
• Clinical Outcomes

Bone Marrow and Stem Cell Transplantation

Reviews donor selection, transplantation approaches, complications, and long-term follow-up.

Myeloproliferative Neoplasms

Relevant disorders include:

• Polycythemia Vera
• Essential Thrombocythemia
• Myelofibrosis
• Molecular Testing
• Thrombotic Risk
• Treatment Planning

Chronic Lymphocytic Leukemia

Reviews CLL diagnosis, prognostic assessment, and contemporary therapy.

Antineoplastic Pharmacology

Examines:

• Cytotoxic Chemotherapy
• Targeted Agents
• Immunotherapy
• Drug Mechanisms
• Treatment Toxicities
• Pharmacological Safety

T-Cell Therapies

Relevant topics include:

• CAR T-Cell Therapy
• Cellular Immunotherapy
• Treatment Selection
• Cytokine Release Syndrome
• Neurotoxicity
• Clinical Monitoring

Live Session 5 – Solid Tumor Oncology

Melanoma

Reviews contemporary systemic and immune-based treatment considerations.

Familial Cancer Syndromes

Examines hereditary cancer predisposition, risk assessment, and genetic evaluation.

Lung Cancer

Important topics include:

• Non-Small Cell Lung Cancer
• Small Cell Lung Cancer
• Molecular Biomarkers
• Immunotherapy
• Targeted Treatment
• Treatment Sequencing

Breast Cancer

Reviews hormone receptor-positive, HER2-positive, and triple-negative disease.

Neuro-Oncology

Examines primary and metastatic central nervous system malignancies.

Endocrine Malignancies

Reviews selected thyroid and other endocrine tumors.

Live Session 6 – Genitourinary, Gynecologic and Other Solid Tumors

Renal Cell Carcinoma

Reviews targeted and immune-based treatments for kidney cancer.

Prostate Cancer

Relevant topics include hormone-sensitive and castration-resistant disease.

Bladder Cancer

Reviews localized and advanced urothelial malignancies.

Testicular Cancer

Examines germ cell tumors and associated treatment considerations.

Ovarian Cancer

Reviews gynecologic oncology developments.

Endometrial Cancer

Examines clinical and molecular treatment strategies.

Head and Neck Cancer

Reviews contemporary treatment approaches.

Carcinoid and Neuroendocrine Tumors

Examines tumor biology, diagnostic assessment, and treatment strategies.

Live Session 7 – Gastrointestinal Oncology and Sarcoma

Gastrointestinal Cancers

Relevant areas include:

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Gastrointestinal Malignancies
• Molecular Testing
• Treatment Selection

Pancreatic Cancer

Reviews:

• Pancreatic Adenocarcinoma
• Staging
• Systemic Treatment
• Multidisciplinary Care
• Supportive Management

Sarcomas

Examines the diagnosis and management of soft tissue and other sarcomas.

Major Topics Covered

• George Washington University Hematology Oncology 2026
• Hematology Board Review
• Medical Oncology Board Review
• ABIM Hematology
• ABIM Medical Oncology
• Benign Hematology
• Immunohematology
• Transfusion Medicine
• Red Cell Disorders
• Anemia
• Hemolysis
• Hemoglobinopathies
• Sickle Cell Disease
• Coagulopathies
• Thrombosis
• Anticoagulation
• Hematopathology
• Bone Marrow Morphology
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• MGUS
• CLL
• CML
• AML
• ALL
• Hematopoietic Stem Cell Transplantation
• CAR T-Cell Therapy
• Oncology Pharmacology
• Cancer Immunotherapy
• Precision Oncology
• Lung Cancer
• Breast Cancer
• Melanoma
• Neuro-Oncology
• Genitourinary Oncology
• Gynecologic Oncology
• Gastrointestinal Oncology
• Pancreatic Cancer
• Sarcomas
• Cancer Genetics
• Palliative Oncology
• Board Examination Preparation

Benign Hematology and Clinical Laboratory Interpretation

Benign hematology requires a detailed understanding of blood cell physiology, coagulation, transfusion practices, and laboratory interpretation.

The course includes extensive education on anemia, red blood cell disorders, platelet abnormalities, bleeding disorders, and thrombosis.

The curriculum emphasizes recognizing characteristic clinical and laboratory findings while selecting appropriate investigations and treatments.

Hematopathology and Cellular Morphology

Blood and bone marrow morphology remain important in hematological diagnosis.

The course incorporates cellular morphology review relevant to differentiating benign and malignant hematological disorders.

Important considerations include:

• Peripheral Blood Smears
• Red Blood Cell Morphology
• White Blood Cell Morphology
• Platelet Findings
• Bone Marrow Evaluation
• Morphologic Diagnostic Clues
• Clinical Laboratory Correlation

Hematologic Malignancies

The malignant hematology curriculum covers major leukemias, lymphomas, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, and related plasma cell disorders.

The educational emphasis includes modern classification, molecular testing, risk stratification, evidence-based treatment, and patient monitoring.

Stem Cell Transplantation and Cellular Immunotherapy

Hematopoietic transplantation and cellular immunotherapy continue to influence the treatment of selected hematologic malignancies.

The course reviews transplantation principles, treatment-related complications, and emerging cellular therapies.

Medical Oncology and Solid Tumors

The medical oncology curriculum addresses major solid tumors across multiple organ systems.

Important areas include:

• Cancer Diagnosis
• Tumor Staging
• Molecular Biomarkers
• Chemotherapy
• Targeted Treatments
• Immunotherapy
• Radiation and Surgical Coordination
• Supportive Care
• Treatment-Related Complications

Precision Medicine and Cancer Genomics

Molecular profiling and biomarker analysis have become important aspects of cancer treatment selection.

The course examines genetic and molecular considerations relevant to hereditary cancer syndromes, targeted therapies, and modern oncology management.

Board Review and Examination Preparation

The original course includes daily board review sessions with interactive case-based questions.

These activities are intended to reinforce major Hematology and Medical Oncology examination concepts.

The program’s comprehensive structure supports review of the ABIM examination blueprint.

Official Course Leadership

Robert S. Siegel, MD

Course Director

Robert S. Siegel, MD, directs the George Washington University Hematology and Oncology Best Practices program.

The course features national clinician-educators and academic specialists across hematology, hematopathology, transfusion medicine, oncology, and related fields.

Individual faculty names and lecture assignments should be taken from the official 2026 syllabus rather than assumed from prior course editions.

Continuing Medical Education

The George Washington University School of Medicine and Health Sciences designated the original 2026 full-program activity for:

• Up to 61 AMA PRA Category 1 Credits™
• Up to 61 ABIM MOC Points

The university provides separate registration options for the full program, Hematology sessions, and Oncology sessions.

Official registration, CME credits, MOC points, and archived recording access are subject to the university’s requirements.

Important CME Notice

Purchasing separately distributed educational files through MedicalAmboss does not itself provide:

• Official George Washington University CME Credits
• ABIM MOC Points
• Board Certification
• Official Completion Certificates
• Original University Registration
• Publisher Learning Platform Access
• Official Archived Recording Access
• University Accounts
• Publisher-Hosted Benefits

Why This Course Is Relevant

The George Washington University Hematology and Medical Oncology Best Practices On Demand 2026 program provides a comprehensive educational review of blood disorders and cancer medicine.

Its broad curriculum integrates benign hematology, transfusion medicine, malignant hematology, cancer pharmacology, cellular therapies, and solid tumor oncology.

The combination of specialty education, cellular morphology review, clinical updates, and examination-oriented preparation makes it particularly relevant to hematologists, oncologists, fellows, residents, and advanced practice providers seeking comprehensive professional education.

Official Program Reference and MedicalAmboss Purchase Scope

Official 2026 On-Demand Course Options:

https://cme.smhs.gwu.edu/hematology-and-oncology-best-practices-courses/content/2026-hematology-and-oncology-best-practices-demand-course-options

Official 2026 Full Program:

https://cme.smhs.gwu.edu/hematology-and-oncology-best-practices-courses/content/2026-hematology-and-oncology-best-practices-full-session

The official references provide information about the original course, available educational tracks, board review structure, accreditation, and publisher registration.

The original university course includes official online access and educational materials for enrolled participants. Those benefits do not automatically transfer to materials offered by a separate retailer.

MedicalAmboss File Scope: This listing describes the educational subject matter for reference. Official university registration, CME or MOC credit, certificates, subscriptions, online platform accounts, memberships, and publisher-hosted extras are not included unless specifically listed as store files.

Short Description

George Washington University Hematology and Medical Oncology Best Practices On Demand 2026 provides a comprehensive, ABIM-focused educational review of benign hematology, hematologic malignancies, medical oncology, cellular therapies, and modern cancer treatment.

Directed by Robert S. Siegel, MD, the original 2026 program covers blood disorders, thrombosis, transfusion medicine, leukemia, lymphoma, multiple myeloma, stem cell transplantation, immunotherapy, and major solid tumors.

Topics

The on-demand curriculum covers the following detailed sessions and lectures:

• Day 0: Hematology / Oncology Enduring Courses

  • Biology of Hematopoiesis

  • Anemia of Chronic Illness

  • Megaloblastic and Sideroblastic Anemias

  • Porphyrias

  • Red Cell Enzymes, Membranes, and Metabolism

  • Mechanisms for Clotting

  • Oral Anticoagulants and Antithrombotic Therapy

  • Parenteral Antithrombotics and Thrombolytic Therapy

  • Review of Cellular Morphology

  • Liquid Biopsies

  • Mesothelioma

• Day 1: Hematology Session

  • ITP and Drug-Induced Thrombocytopenia

  • Hemolytic Anemia

  • Consumptive Thrombohemorrhagic Disorders (DIC, TTP, HUS)

  • The Hemophilias

  • Hypercoagulable States

  • Von Willebrand’s Disease

  • Qualitative Platelet Defects

  • Acquired Disorders of Coagulation

  • Transfusion Medicine

  • Platelet Alloimmunization

• Day 2: Hematology Session

  • Iron Deficiency and Overload

  • Hemoglobinopathies

  • Bone Marrow Failure

  • White Cell Disorders

  • Anti-PF4 Disorders (HIT, VITT), DIC and Ischemic Limb Gangrene

  • Sickling Disorders

  • ABO Incompatibility and Other Transfusion-Related Issues in Hematopoietic Transplantation

  • Hematologic Complications of Pregnancy

• Day 3: Hematologic Malignancies

  • Pathology of Lymphomas

  • Non-Hodgkin’s Lymphoma

  • Myelodysplasia

  • Hodgkin’s Lymphoma

  • Acute Lymphocytic Leukemia

  • Chronic Myeloid Leukemia

  • Multiple Myeloma, Plasmacytoma, and MGUS

  • Waldenstrom’s Macroglobulinemia and Amyloidosis

  • Palliative Care

• Day 4: Hematologic Malignancies

  • Acute Myeloid Leukemia

  • Bone Marrow Transplantation

  • Myeloproliferative Neoplasms

  • Pharmacology I

  • Chronic Lymphocytic Leukemia

  • Pharmacology II

  • Pharmacology III

  • T Cell Therapies for Cancer

• Day 5: Oncology Session

  • Melanoma

  • Familial Cancer Syndromes

  • Non-Small Cell Lung Cancer

  • Small Cell Lung Cancer

  • Adjuvant Therapy for Breast Cancer

  • Metastatic Breast Cancer

  • Neuro-Oncology

  • Metastatic Disease to the Brain, Spine, Carcinomatous Meningitis

  • Endocrine Malignancies

• Day 6: Oncology Session

  • Renal Cell Cancer

  • Prostate Cancer

  • Bladder Cancer

  • Testicular Cancer and Mediastinal Germ Cell Tumors

  • Ovarian Cancer

  • Endometrial Cancer

  • Cancer of the Cervix, Vulva, Vagina and Gestational Trophoblastic Tumors

  • Head and Neck Cancer

  • Carcinoid Tumors, Carcinoid Syndrome and Pancreatic Neuroendocrine Tumors

• Day 7: Oncology Session

  • Esophageal Carcinoma

  • Gastric Cancer

  • Adjuvant Therapy for Colon and Rectal Cancer

  • Pancreatic Cancer

  • Metastatic Therapy for Colon and Rectal Cancer

  • Anal Cancer

  • Sarcoma

  • Hepatobiliary Cancer